drugset / Trial / NCT04905654

Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura

NCT04905654

Completed 35 enrolled Danish Headache Center
RandomizedCrossoverQuadruple-blindOther

Summary

To investigate the migraine inducing effect of levcromakalim in patients with migraine with aura.

Timeline

Start
2021-09-29
Primary completion
2023-05-16
Completion
2023-05-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levcromakalim Small molecule Intravenous

Indications